Gene · 57016
Papers1,760
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,760
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Castanea sativa Shells (CSSs) as a Source of AKR1B1 and AKR1B10 Inhibitors: From Extraction to Bioactivity Testing. | Molecules | 2026 | 41683538 | PubTator, text mining | PubMed |
| Biomarker discovery and drug repurposing in hepatocellular carcinoma through transcriptomics, machine learning, network pharmacology, and molecular dynamics. | Comput Biol Chem | 2026 | 41671946 | PubTator, text mining | PubMed |
| AKR1B10 reprograms neutrophils by histone lactylation to foster immune evasion in KRASG12C mutation colorectal cancer liver metastasis. | J Exp Clin Cancer Res | 2026 | 41630031 | PubTator, text mining | PubMed |
| Experimental Evidence That Prenatal and Postnatal Developmental Stress Affects the Adult Seminal Fluid Proteome in a Precocial Bird. | Mol Ecol | 2026 | 41607174 | PubTator, text mining | PubMed |
| A New Histology-Based Prognostic Index for Acute Lymphoblastic Leukemia: Preliminary Results of the "ALL Urayasu Classification". | J Clin Med | 2026 | 41598705 | PubTator, text mining | PubMed |
| Targeting AKR1B1 reprograms tumor-associated macrophages to enhance antitumor immunity. | J Immunother Cancer | 2026 | 41592892 | PubTator, text mining | PubMed |
| Correction to: Arugula‑derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41557070 | PubTator, text mining | PubMed |
| A biology-informed radiomics model for prognostication of hepatocellular carcinoma based on AKR1B10 expression. | Eur J Radiol Open | 2026 | 41550669 | PubTator, text mining | PubMed |
| Isothermal real-time RT-RPA for Machupo virus detection: Field-adaptable sensitivity comparable with laboratory PCR. | PLoS One | 2026 | 41525354 | PubTator, text mining | PubMed |
| Arugula-derived isothiocyanates as novel agents for a potential regulator of AKR1B10 protein in breast cancer: an integrated transcriptomic and molecular docking approach. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41454951 | PubTator, text mining | PubMed |
| AARS1-mediated AKR1B10 lactylation stabilizes an aerobic glycolysis-positive feedback loop to drive lenvatinib resistance in hepatocellular carcinoma. | Clin Transl Med | 2026 | 41454479 | PubTator, text mining | PubMed |
| Identification of key pathways and biomarkers in rheumatoid arthritis synovial tissue through comprehensive transcriptomic integration. | J Orthop | 2026 | 41209768 | PubTator, text mining | PubMed |
| Enhancing ferroptosis and inhibiting ABCB1 make the novel aldose reductase inhibitor 5F-E a promising sensitizer in liver cancer. | Pharm Sci Adv | 2025 | 41550647 | PubTator, text mining | PubMed |
| Deciphering the molecular basis of skin color variation through transcriptomics and machine learning. | Sci Rep | 2025 | 41419520 | PubTator, text mining | PubMed |
| Systems pharmacology approaches decipher the anti-cancer efficacy of ethnopharmacological agents in hepatocellular carcinoma. | Sci Rep | 2025 | 41408124 | PubTator, text mining | PubMed |
| A pooled Cell Painting CRISPR screening platform enables de novo inference of gene function by self-supervised deep learning. | Nat Commun | 2025 | 41402283 | PubTator, text mining | PubMed |
| A Multidimensional Study Integrating Traditional Chinese Medicine and Network Pharmacology: Exploring the Skin Repair and Anti-Aging Effects of a Specific Combination of Five-Colored Plants. | Clin Cosmet Investig Dermatol | 2025 | 41340883 | PubTator, text mining | PubMed |
| Integrated machine learning and causal inference reveal CHRDL1 as a diagnostic and functional biomarker in NSCLC. | Discov Oncol | 2025 | 41258297 | PubTator, text mining | PubMed |
| Dual tissue mRNA and serum protein signatures improve risk stratification in hepatocellular carcinoma. | NPJ Precis Oncol | 2025 | 41249833 | PubTator, text mining | PubMed |
| Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations. | Explor Target Antitumor Ther | 2025 | 41216224 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57016/papers?page=3